Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis

Kidney International

Volumn 53, Issue 4, 1998, Pages 897-908

  Thomas, Susan E ^a   Andoh, Takeshi F ^b   Pichler, Raimund H ^b   Shankland, Stuart J ^b   Couser, William G ^b   Bennett, William M ^b   Johnson, Richard J ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b NONE

Author keywords

Angiotensin II; Apoptosis; Cyclosporine; Macrophage; Nitric oxide; Tubulointerstitial fibrosis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ARGININE; CYCLOSPORIN A; FUROSEMIDE; HYDRALAZINE; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MACROPHAGE; MALE; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031957453     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.1998.00835.x     Document Type: Article

References (66)

1. ELZINGA LW, ROSEN S, BENNETT WM: Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake. J Am Soc Nephrol 4:214-221, 1993
2. YOUNG BA, BURDMANN EA, JOHNSON RJ, ALPERS CE, GIACHELLI CM, ENG E, ANDOH T: Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephropathy. Kidney Int 48:439-448, 1995
3. BOREL JF, FEURER C, GUBLER HU, STAHELIN H: Biological effects of cyclosporin A: A new antilymphocytic agent. Agent Actions 6:468-475, 1976
4. POWLES AV, COOK T, HULME B, BAKER BS, LEWIS HM, THOMAS E, VALDIMARSSON H, FRY L: Renal function and biopsy findings after 5 years' treatment with low-dose cyclosporin for psoriasis. Br J Dermatol 128:159-165, 1993
5. PALLESTINE AG, AUSTIN HA III, BALOW JE, ANTONOVYCH TT, SABNIS SG, PREUSS HG, NUSSENBLATT RB: Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Enql J Med 314:1293-1298, 1986
6. CALNE RY, WHITE DJG, THIRU S, EVANS DB, MCMASTER P, DUNN DC, CRADDOCK GN, PENTLOW BD, ROLLES K: Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2:1323-1327, 1978
7. HUMES HD, COFFMAN T, HALDERMAN H, MIHATSCH M, HENRY M, PORTER GA: Cyclosporine nephrotoxicity: A workshop to discuss mechanisms, diagnosis, and treatment. Transplant Proc 20:833-840, 1988
8. YOUNG BA, MARSH CL, ALPERS CE, DAVIS CL: Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation. Am J Kidney Dis 4:561-571, 1996
9. PICHLER RH, FRANCESCHINI N, YOUNG BA, HUGO C, ANDOH T, BURDMANN EA, SHANKLAND SJ, ALPERS CE, BENNETT WM, COUSER WG, JOHNSON RJ: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196, 1995
10. YOUNG BA, BURDMANN EA, JOHNSON RJ, ANDOH T, BENNETT WM, COUSER WG, ALPERS CE: Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int 48:431-438, 1995
11. BENNETT WM: Insights into chronic cyclosporine nephrotoxicity. Int J Clin Pharmacol Ther 34:515-519, 1996
12. AMORE A, GIANOGLIO B, GHIGO D, PERUZZI L, PORCELLINI MG, BUSSOLINO F, COSTAMAGNNA C, CACACE G, PICCIOTTO G, MAZZUCCO G, SENA LM, COPPO R: A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. Kidney Int 47:1507-1514, 1995
13. GARDNER MP, HOUGHTON DC, ANDOH TF, LINDSLEY J, BENNETT WM: Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition. Transplantation 61:1506-1512, 1996
14. JOHNSON RJ, GARCIA RL, PRITZL P, ALPERS CE: Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 136:369-374, 1990
15. COLES HSR, BURNE JF, RAFF MC: Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118:777-784, 1993
16. BAKER AJ, MOONEY A, HUGHES J, LOMBARDI D, JOHNSON RJ, SAVILL J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105-2116, 1994
17. JOHNSON RJ, ALPERS CE, PRUCHNO C, SCHULZE M, BAKER PJ, PRITZL P, COUSER WG: Mechanisms and kinetics for platelet and neutrophil localization in immune complex nephritis. Kidney Int 36:780-789, 1989
18. SAVILL J, HASLETT C: Granulocyte clearance by apoptosis in the resolution of inflammation. Semin Cell Biol 6:385-393, 1995
19. WALLENSTEIN S, ZUCKER CL, FLEISS JL: Some statistical methods useful in circulation research. Circ Res 47:1-9, 1980
20. SAVILL J: Apoptosis and the kidney. J Am Soc Nephrol 5:12-21, 1994
21. SAVILL J: Apoptosis: Will cell death add life to nephrology? Nephrol Dial Transplant 10:1977-1979, 1995
22. SUGIYAMA H, KASHIHARA N, MAKINO H, YAMASAKI Y, OTA Z: Apoptosis in glomerular sclerosis. Kidney Int 49:103-111, 1996
23. SHIMIZU A, KITAMURA H, MASUDA Y, ISHIZAKI M, SUGISAKI Y, YAMANAKA N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47:114-121, 1995
24. ITO H, KASAGI N, SHOMORI K, OSAKI M, ADACHI H: Apoptosis in the human allografted kidney. Transplantation 60:794-798, 1995
25. SAVILL J, DRANSFIELD I, HOGG N, HASLETT C: Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343:170-173, 1990
26. GOLD R, SCHMIED M, GIEGERICH G, BREITSCHOPF H, HARTUNG HP, TOYKA KV, LASSMANN H: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71:219-225, 1994
27. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZL P, FLOEGE J, SCHWARTZ SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
28. KLIEM V, JOHNSON RJ, ALPERS CE, YOSHIMURA A, COUSER WG, KOCH KM, FLOEGE J: Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 49: 666-678, 1996
29. NEWMAN SL, HENSON JE, HENSON PM: Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J Exp Med 156:430-442, 1982
30. SANUI H, YOSHIDA S, NOMOTO K, OHHARA R, ADACHI Y: Peritoneal macrophages which phagocytose autologous polymorphonuclear leucocytes in guinea-pigs I: Induction by irritants and microorganisms and inhibition by colchicine. Br J Exp Pathol 63:278-284, 1982
31. SAVILL JS, WYLLIE AH, HENSON JE, WALPORT MJ, HENSON PM, HASLETT C: Macrophage phagocytosis of aging neutrophils in inflammation. J Clin Invest 83:865-875, 1989
32. SAVILL J, SMITH J, SARRAF C, REN Y, ABBOTT F, REES A: Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int 42:924-936, 1992
33. SAVILL J: Apoptosis in disease. Eur J Clin Invest 24:715-723, 1994
34. SAVILL J, HOGG N, REN Y, HASLETT C: Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 90:1513-1522
35. SAVILL J, FADOK V, HENSON P, HASLETT C: Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131-136, 1993
36. REN Y, SILVERSTEIN RL, ALLEN J, SAVILL J: CD36 gene transfer confers capacity for phagocytosis of cells undercoing apoptosis. J Exp Med 181:1857-1862, 1995
37. REN Y, SAVILL J: Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J Immunol 154:2366-2374, 1995
38. STERN M, SAVILL J, HASLETT J: Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Am J Pathol 149:911-921, 1996
39. NAVAZO MDP, DAVIET L, SAVILL J, REN Y, LEUNG LLK, MCGREGOR JL: Identification of a domain (155-183) on CD36 implicated in the phagocytosis of apoptotic neutrophils. J Biol Chem 271:15381-15385, 1996
40. LAFAYETTE RA, MAYER G, MEYER T: The effect of blood pressure reduction on cyclosporine nephrotoxicity in the rat. J Am Soc Nephrol 3:1892-1899, 1993
41. BURDMANN EA, ANDOH TF, NAST CC, EVAN A, CONNORS BA, COFFMAN TM, LINDSLEY J, BENNETT WM: Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 269:F491-F499, 1995
42. FAUBERT PF, CHOU SY, PORUSH JG: Regulation of papillary plasma flow by angiotensin II. Kidney Int 32:472-478, 1987
43. MYERS BD, DEEN WM, BRENNER BM: Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 37:101-110, 1975
44. MATSUSAKA T, HYMES J, ICHIKAWA I: Angiotensin in progressive renal diseases: Theory and practice. J Am Soc Nephrol 7:2025-2043, 1996
45. SHIHAB FS, ANDOH TF, TANNER AM, NOBLL NA, BORDER WA, FRANCESCHINI N, BENNETT WM: Role of transforming growth factor-B1 in experimental chronic cyclosporine nephropathy. Kidney Int 49:1141-1151, 1996
46. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates extracellular matix protein synthesis through induction of transforming growth factor-B expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
47. WOLF G, MUELLER E, STAHL RAK, ZIYADEH FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-B. J Clin Invest 92:1366-1372, 1993
48. DE NICOLA L, THOMSON SC, WEAD LM, BROWN MR, GABBAI FB: Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 92:1859-1865, 1993
49. BLOOM ITM, BENTLEY FR, SPAIN DA, GARRISON RN: An experimental study of altered nitric oxide metabolism as a mechanism of cyclosporin-induced renal vasoconstriction. Br J Surgery 82:195-198, 1995
50. GASTON RS, SCHLESSINGER SD, SANDERS PW, BARKER CV, CURTIS JJ, WARNOCK DG: Cyclosporine inhibits the renal response to L-arginine in human kidney transplant patients. J Am Soc Nephrol 5:1426-1433, 1995
51. STEPHAN D, BILLING A, KRIEGER JP, GRIMA M, FABRE M, HOFNER M, IMBS JL, BARTHELMEBS M: Endothelum-dependent relaxation in the isolated rat kidney: Impairment by cyclosporine A. J Cardiovasc Phamacol 26:859-868, 1995
52. CHEVALIER RL: Growth factors and apoptosis in neonatal ureteral obstruction. J Am Soc Nephrol 7:1098-1105, 1996
53. TRUONG LD, PETRUSEVSKA G, YANG G, GURPINAR T, SHAPPELL S, LECHAGO J, ROUSE D, SUKI W: Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 50:200-207, 1996
54. KENNEDY II WA, STENBERG A, LACKGREN G, HENSLE TW, SAWCZUK IS: Renal tubular apoptosis after partial ureteral obstruction. J Urol 152:658-664, 1994
55. SAVILL J, MOONEY A, HUGHES J: Apoptosis and renal scarring. Kidney Int 49(Suppl 54):S14-S17, 1996
56. JOHNSON RJ: The glomerular response to injury: Progression or resolution? Kidney Int 45:1769-1782, 1994
57. SAVILL J, JOHNSON RJ: Glomerular remodelling after inflammatory injury. Exp Nephrol 3:149-159, 1995
58. KON V, SUGIURA M, INAGAMI T, HARVIE BR, ICHIKAWA I, HOOVER RL: Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 37:1487-1491, 1990
59. FOGO A, HELLINGS SE, INAGAMI T, KON V: Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int 42:770-774, 1992
60. LANESE DM, CONGER JD: Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 91:2144-2149, 1993
61. MURRAY BM, PALLER MS, FERRIS TF: Effect of cyclosporine administation on renal hemodynamics in conscious rats. Kidney Int 28:767-774, 1985
62. ELZINGA LW, ROSEN S, BURDMANN EA, LINDSLEY J, HATTON DC, BENNETT WM: Effects of renal denervation in a model of chronic cyclosporine (CsA) nephropathy. (abstract) J Am Soc Nephrol 5:920, 1994
63. 2 receptor antagonists on cyclosporine A renal vasoconstriction. Am J Physiol 267:F443-F449, 1994
64. NEILD GH, ROCCHI G, IMBERTI L, FUMAGALLI G, BROWN Z, REMUZZI G, WILLIAMS DG: Effect of cyclosporin A on prostacyclin synthesis by vascular tissue. Thromb Res 32:373-379, 1983
65. BROOKS DP, DRUTZ DJ, RUFFOLO RR: Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam. J Pharmacol Exp Ther 254:375-379, 1990
66. SHEMATA M, EL NAHAS M, BARKWORTH E, COPE GH, RAFTERY AT: Increased platelet-derived growth factor in the kidneys of cyclosporin-treated rats. Kidney Int 46:726-732, 1994